News

Displaying 401 - 420 of 734

Drug-related harms and responses in focus at annual EMCDDA expert meetings

Latest evidence in the area of drug overdose, HCV infections and HIV outbreaks among drug users will be among the topics discussed in a series of events unfolding this week at the...

Second EMDAS graduation ceremony at EMCDDA

The second group of 25 students graduating from the European Masters in Drug and Alcohol Studies (EMDAS), will receive their diplomas at a ceremony at the EMCDDA on 30 September (1). EMDAS...

Four new drugs to be placed under control

Today, EU Ministers adopted a European Commission proposal to control four new psychoactive substances currently raising health concerns in Europe. With today's decision, the substances MDPV, methoxetamine, AH-7921, and 25I-NBOMe will be...

EMCDDA unites expert networks in integrated approach to monitoring

‘Continuity and change: high-risk drug use and drug treatment in Europe’, is the focus of events unfolding this week at the EU drugs agency (EMCDDA) in Lisbon (1). Two parallel EMCDDA expert...

European Parliament President Martin Schulz to visit EU agencies in Lisbon

Newly re-elected President of the European Parliament Martin Schulz will visit the EU drugs agency (EMCDDA) and the European Maritime Safety Agency (EMSA) on 23 September, accompanied by Secretary of State for...

ECDC-EMCDDA mission on HIV status and hepatitis surveillance in Latvia

At the invitation of the Latvian government, and in the context of high HIV levels in the country, ECDC and the EMCDDA have joined forces to assist national experts in preventing and...

Published today on World Hepatitis Day: New EMCDDA review on hepatitis C virus infection among people who inject drugs in Europe

People who inject drugs (PWID) are a key population affected by the hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. To...

Eurojust and EMCDDA pledge to boost cooperation

Exchanging strategic and technical information in the areas of drug legislation and supply was among the pledges made today in a Memorandum of Understanding (MoU) signed by the EU drugs agency (EMCDDA)...

Third European drugs summer school opens today in Lisbon

The third European drugs summer school (EDSS) — ‘Illicit drugs in Europe: demand, supply and public policies’ — opens today in Lisbon and will run until 11 July. The initiative, organised by...

26 June: International day against drug abuse and illicit trafficking

An estimated 28 000 lives are lost on Europe’s roads every year and a further 1.34 million people are injured (1). Many of these accidents and deaths are caused by drivers whose...

EU drugs agency places six topics in the spotlight with new online analyses

The EU drugs agency (EMCDDA) releases today alongside its European Drug Report 2014: Trends and developments, six new additions to its Perspectives on drugs (PODs) series. This latest selection of online, interactive...

European Drug Report out today — Europe’s drugs problem ‘increasingly complex’

Europe’s drugs problem is becoming increasingly complex with new challenges emerging that raise concerns for public health. This is according to the European Drug Report 2014: Trends and developments released today by...

Largest multi-city study on drug wastewater analysis released today

The findings of the largest European project to date in the emerging science of wastewater analysis (WWA) are released today in an article published in Addiction (1). The project in question —...

International experts to examine latest findings in the field of new drugs

International experts gather in Rome today to examine the latest scientific research in the rapidly-changing field of novel (or new) psychoactive substances (NPS). They will be participating in the Third international conference...

EU drugs agency to launch European Drug Report 2014

The EU drugs agency (EMCDDA) will be presenting its annual overview of the European drug situation on 27 May in a multilingual, multimedia information package focusing on today’s rapidly shifting drug phenomenon...

EMCDDA and ECDC facilitate sub-regional exchange of knowledge and best practice in monitoring and preventing drug-related infections

Monitoring and responding to HIV and hepatitis C among people who inject drugs (PWID) is the focus of two new reports from the EU drugs agency (EMCDDA) and the European Centre for...

Scientific Committee — elections for chair and vice chair

The EMCDDA Scientific Committee, meeting in Lisbon this week, elected its new Chair and Vice Chair for the next three years. Prof. Dr Gerhard Bühringer (Germany) was elected to the position of...

Regional drug strategies across the world explored in new EMCDDA paper

The EU drugs agency (EMCDDA) has released today its first comparative analysis of regional drug strategies across the world (1). The paper explores the drug strategies and action plans adopted over the...

Dangerous synthetic drugs hit the EU market

Europol and the EMCDDA have issued today early-warning notifications about two synthetic drugs that have recently been linked to serious harms in the EU. The first concerns a new psychoactive substance associated...

New EMCDDA technical assistance project with ENP countries kicks off today

A new, two-year technical cooperation project between the EU drugs agency (EMCDDA) and countries of the European Neighbourhood Policy (ENP) kicks off today in Lisbon (1). The project takes place within the...